Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jean-Michel Pawlotsky
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Chemicals & Drugs
Physiology
Procedures
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
62
Dhumeaux, Daniel
35
Roudot-Thoraval, Françoise
21
Chevaliez, Stéphane
20
Hézode, Christophe
18
Zafrani, Elie Serge
17
Bastie, Anne
16
Germanidis, Georgios
14
Darthuy, Françoise
12
Neumann, Avidan
11
Bouvier-Alias, Magali
11
Lefrère, Jean-Jacques
10
Hezode, Christophe
10
Zeuzem, Stefan
9
Schalm, Solko
9
Duvoux, Christophe
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jean-Michel Pawlotsky (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Pawlotsky Jean-Michel
Hepatitis: HCV variability, the immune system and resistance to antiviral drugs.
Nature reviews. Gastroenterology & hepatology 2009;6(7):383-5.
-
2009: Chevaliez Stéphane; Bouvier-Alias Magali; Pawlotsky Jean-Michel
Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification.
Journal of clinical microbiology 2009;47(6):1726-32.
-
2009: Morice Yoann; Ratinier Maxime; Miladi Ahmed; Chevaliez Stéphane; Germanidis Georgios; Wedemeyer Heiner; Laperche Syria; Lavergne Jean-Pierre; Pawlotsky Jean-Michel
Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.
Hepatology (Baltimore, Md.) 2009;49(5):1449-59.
-
2009: Hézode Christophe; Forestier Nicole; Dusheiko Geoffrey; Ferenci Peter; Pol Stanislas; Goeser Tobias; Bronowicki Jean-Pierre; Bourlière Marc; Gharakhanian Shahin; Bengtsson Leif; McNair Lindsay; George Shelley; Kieffer Tara; Kwong Ann; Kauffman Robert S; Alam John; Pawlotsky Jean-Michel; Zeuzem Stefan;
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
The New England journal of medicine 2009;360(18):1839-50.
-
2009: Chevaliez Stéphane; Bouvier-Alias Magali; Castéra Laurent; Pawlotsky Jean-Michel
The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples.
Hepatology (Baltimore, Md.) 2009;49(4):1397-8.
-
2009: Pawlotsky Jean-Michel
EASL Clinical Practice Guidelines.
Journal of hepatology 2009;50(2):243.
-
2009: Chevaliez Stéphane; Pawlotsky Jean-Michel
Virological techniques for the diagnosis and monitoring of hepatitis B and C.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2009;8(1):7-12.
-
2009: Chevaliez Stéphane; Pawlotsky Jean-Michel
How to use virological tools for optimal management of chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver 2009;29 Suppl 1():9-14.
-
2009: Pallier Coralie; Rodriguez Christophe; Brillet Rozenn; Nordmann Patrice; Hézode Christophe; Pawlotsky Jean-Michel
Complex dynamics of hepatitis B virus resistance to adefovir.
Hepatology (Baltimore, Md.) 2009;49(1):50-9.
-
2009: Chevaliez Stéphane; Pawlotsky Jean-Michel
Interferons and their use in persistent viral infections.
Handbook of experimental pharmacology 2009;(189):203-41.
-
2008: Raimondo Giovanni; Allain Jean-Pierre; Brunetto Maurizia R; Buendia Marie-Annick; Chen Ding-Shinn; Colombo Massimo; Craxì Antonio; Donato Francesco; Ferrari Carlo; Gaeta Giovanni B; Gerlich Wolfram H; Levrero Massimo; Locarnini Stephen; Michalak Thomas; Mondelli Mario U; Pawlotsky Jean-Michel; Pollicino Teresa; Prati Daniele; Puoti Massimo; Samuel Didier; Shouval Daniel; Smedile Antonina; Squadrito Giovanni; Trépo Christian; Villa Erica; Will Hans; Zanetti Alessandro R; Zoulim Fabien
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Journal of hepatology 2008;49(4):652-7.
-
2008: Challine Dominique; Chevaliez Stéphane; Pawlotsky Jean-Michel
Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Gastroenterology 2008;135(4):1185-91.
-
2008: Girou Emmanuelle; Chevaliez Stéphane; Challine Dominique; Thiessart Michaël; Morice Yoann; Lesprit Philippe; Tkoub-Scheirlinck Latifa; Soing-Altrach Sophan; Cizeau Florence; Cavin Celine; André Martine; Dahmanne Djamel; Lang Philippe; Pawlotsky Jean-Michel
Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):627-33.
-
2008: Piodi Aurélie; Chouteau Philippe; Lerat Hervé; Hézode Christophe; Pawlotsky Jean-Michel
Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Hepatology (Baltimore, Md.) 2008;48(1):16-27.
-
2008: Germanidis Georgios; Metallidis Simeon; Lazaraki Georgia; Pawlotsky Jean Michel; Nikolaidis Paul
NS5A sequences of hepatitis C virus genotype 1 and interferon resistance: where are we?
The Journal of infectious diseases 2008;198(1):154-5.
-
2008: Pugnale Paolo; Herrmann Eva; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Ferrari Carlo; Homburger Yonit; Zeuzem Stefan; Negro Francesco;
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
Journal of hepatology 2008;48(6):932-8.
-
2008: Pawlotsky Jean-Michel
Building a liver disease policy in the European Union.
Journal of hepatology 2008;48(6):889-91.
-
2008: Chevaliez Stéphane; Bouvier-Alias Magali; Laperche Syria; Pawlotsky Jean-Michel
Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.
Journal of clinical microbiology 2008;46(5):1716-23.
-
2008: Keeffe Emmet B; Dieterich Douglas T; Pawlotsky Jean-Michel; Benhamou Yves
Chronic hepatitis B: preventing, detecting, and managing viral resistance.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(3):268-74.
-
2008: Pawlotsky Jean-Michel; Dusheiko Geoffrey; Hatzakis Angelos; Lau Daryl; Lau George; Liang T Jake; Locarnini Stephen; Martin Paul; Richman Douglas D; Zoulim Fabien
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.
Gastroenterology 2008;134(2):405-15.
-
2008: Smyk-Pearson Susan; Tester Ian A; Klarquist Jared; Palmer Brent E; Pawlotsky Jean-Michel; Golden-Mason Lucy; Rosen Hugo R
Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.
Journal of virology 2008;82(4):1827-37.
-
2008: Westin Johan; Ydreborg Magdalena; Islam Sara; Alsiö Asa; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; Ferrari Carlo; Neumann Avidan U; Hellstrand Kristoffer; Lagging Martin;
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.
Scandinavian journal of gastroenterology 2008;43(1):73-80.
-
2008: Pawlotsky J-M
[Virologic techniques for the diagnosis and monitoring of hepatitis B]
Gastroentérologie clinique et biologique 2008;32(1 Pt 2):S56-63.
-
2008: Chevaliez Stéphane; Pawlotsky Jean-Michel
Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
Best practice & research. Clinical gastroenterology 2008;22(6):1031-48.
-
2007: Chevaliez S; Pawlotsky J-M
Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
Journal of viral hepatitis 2007;14 Suppl 1():77-81.
-
2007: Laperche Syria; Bouchardeau Françoise; Thibault Vincent; Pozzetto Bruno; Vallet Sophie; Rosenberg Arielle R; Roque-Afonso Anne-Marie; Gassin Michèle; Stoll-Keller Françoise; Trimoulet Pascale; Gault Elyanne; Chanzy Bruno; Mercier Bernard; Branger Michel; Pawlotsky Jean-Michel; Henquell Cécile; Lunel Françoise; Gaudy-Graffin Catherine; Alain Sophie; Chaix Marie-Laure; Duverlie Gilles; Izopet Jacques; Lefrère Jean-Jacques
Multicenter trials need to use the same assay for hepatitis C virus viral load determination.
Journal of clinical microbiology 2007;45(11):3788-90.
-
2007: de Araújo Evaldo Stanislau Affonso; Mendonça João Silva; Barone Antonio Alci; Gonçales Fernando Lopes; Ferreira Marcelo Simão; Focaccia Roberto; Pawlotsky Jean-Michel
Consensus of the Brazilian Society of Infectious Diseases on the management and treatment of hepatitis C.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2007;11(5):446-50.
-
2007: Pilli Massimo; Zerbini Alessandro; Penna Amalia; Orlandini Alessandra; Lukasiewicz Esther; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; von Wagner Michael; Germanidis Georgios; Lurie Yoav; Esteban Juan I; Haagmans Bart L; Hezode Christophe; Lagging Martin; Negro Francesco; Homburger Yonit; Neumann Avidan U; Ferrari Carlo; Missale Gabriele;
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
Gastroenterology 2007;133(4):1132-43.
-
2007: Chevaliez Stéphane; Pawlotsky Jean-Michel
Interferon-based therapy of hepatitis C.
Advanced drug delivery reviews 2007;59(12):1222-41.
-
2007: Marcellin Patrick; Bourlière Marc; Pawlotsky Jean-Michel; Ouzan Denis
[HCV non-responder patients: definition of non-response and treatment strategy]
Gastroentérologie clinique et biologique 2007;31(8-9 Pt 3):4S13-9.
-
2007: Lok Anna S; Zoulim Fabien; Locarnini Stephen; Bartholomeusz Angeline; Ghany Marc G; Pawlotsky Jean-Michel; Liaw Yun-Fan; Mizokami Masashi; Kuiken Carla;
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Hepatology (Baltimore, Md.) 2007;46(1):254-65.
-
2007: Chevaliez Stéphane; Bouvier-Alias Magali; Brillet Rozenn; Pawlotsky Jean-Michel
Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.
Hepatology (Baltimore, Md.) 2007;46(1):22-31.
-
2007: Chevaliez Stéphane; Brillet Rozenn; Lázaro Ester; Hézode Christophe; Pawlotsky Jean-Michel
Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
Journal of virology 2007;81(14):7732-41.
-
2007: Chevaliez Stéphane; Pawlotsky Jean-Michel
Hepatitis C virus: virology, diagnosis and management of antiviral therapy.
World journal of gastroenterology : WJG 2007;13(17):2461-6.
-
2007: Pawlotsky Jean-Michel; Chevaliez Stéphane; McHutchison John G
The hepatitis C virus life cycle as a target for new antiviral therapies.
Gastroenterology 2007;132(5):1979-98.
-
2007: Westin Johan; Hellstrand Kristoffer; Alsiö Asa; Ydreborg Magdalena; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Verhey-Hart Elke; Lagging Martin
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2007;45(5):1333-4; author reply 1334.
-
2007: Hézode Christophe; Chevaliez Stéphane; Bouvier-Alias Magali; Roudot-Thoraval Françoise; Brillet Rozenn; Zafrani Elie-Serge; Dhumeaux Daniel; Pawlotsky Jean-Michel
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
Journal of hepatology 2007;46(5):791-6.
-
2007: Pawlotsky Jean-Michel
Treatment of hepatitis C: don't put all your eggs in one basket!
Gastroenterology 2007;132(4):1611-5.
-
2007: Bouchardeau Françoise; Cantaloube Jean François; Chevaliez Stéphane; Portal Christine; Razer Annie; Lefrère Jean-Jacques; Pawlotsky Jean Michel; De Micco Philippe; Laperche Syria
Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay.
Journal of clinical microbiology 2007;45(4):1140-5.
-
2007: Brillet Rozenn; Penin François; Hezode Christophe; Chouteau Philippe; Dhumeaux Daniel; Pawlotsky Jean-Michel
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
The Journal of infectious diseases 2007;195(3):432-41.
-
2007: Westin J; Lagging M; Dhillon A P; Norkrans G; Romero A I; Pawlotsky J-M; Zeuzem S; Schalm S W; Verheij-Hart E; Negro F; Missale G; Neumann A U; Hellstrand K;
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
Journal of viral hepatitis 2007;14(1):29-35.
-
2007: Lukasiewicz Esther; Hellstrand Kristoffer; Westin Johan; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Veldt Bart J; Hansen Bettina E; Verhey-Hart Elke; Lagging Martin
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Hepatology (Baltimore, Md.) 2007;45(1):258-9.
-
2007: Combet Christophe; Garnier Nicolas; Charavay Céline; Grando Delphine; Crisan Daniel; Lopez Julien; Dehne-Garcia Alexandre; Geourjon Christophe; Bettler Emmanuel; Hulo Chantal; Le Mercier Philippe; Bartenschlager Ralf; Diepolder Helmut; Moradpour Darius; Pawlotsky Jean-Michel; Rice Charles M; Trépo Christian; Penin François; Deléage Gilbert
euHCVdb: the European hepatitis C virus database.
Nucleic acids research 2007;35(Database issue):D363-6.
-
2007: Griveas I; Germanidis G; Visvardis G; Morice Y; Perelson A S; Pawlotsky J M; Papadopoulou D
Acute hepatitis C in patients receiving hemodialysis.
Renal failure 2007;29(6):731-6.
-
2006: Lagging Martin; Romero Ana I; Westin Johan; Norkrans Gunnar; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; von Wagner Michael; Negro Francesco; Schalm Solko W; Haagmans Bart L; Ferrari Carlo; Missale Gabriele; Neumann Avidan U; Verheij-Hart Elke; Hellstrand Kristoffer;
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
Hepatology (Baltimore, Md.) 2006;44(6):1617-25.
-
2006: Perrin L; Pawlotsky J M; Bouvier-Alias M; Sarrazin C; Zeuzem S; Colucci G
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load.
Journal of clinical microbiology 2006;44(12):4371-5.
-
2006: Kuiken Carla; Combet Christophe; Bukh Jens; Shin-I Tadasu; Deleage Gilbert; Mizokami Masashi; Richardson Russell; Sablon Erwin; Yusim Karina; Pawlotsky Jean-Michel; Simmonds Peter;
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.
Hepatology (Baltimore, Md.) 2006;44(5):1355-61.
-
2006: Bronowicki Jean-Pierre; Ouzan Denis; Asselah Tarik; Desmorat Hervé; Zarski Jean-Pierre; Foucher Juliette; Bourlière Marc; Renou Christophe; Tran Albert; Melin Pascal; Hézode Christophe; Chevalier Michelle; Bouvier-Alias Magali; Chevaliez Stéphane; Montestruc François; Lonjon-Domanec Isabelle; Pawlotsky Jean-Michel
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Gastroenterology 2006;131(4):1040-8.
-
2006: Laperche Syria; Thibault Vincent; Bouchardeau Françoise; Alain Sophie; Castelain Sandrine; Gassin Michelle; Gueudin Marie; Halfon Philippe; Larrat Sylvie; Lunel Françoise; Martinot-Peignoux Michèle; Mercier Bernard; Pawlotsky Jean-Michel; Pozzetto Bruno; Roque-Afonso Anne-Marie; Roudot-Thoraval Françoise; Sauné Karine; Lefrère Jean-Jacques
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.
Journal of clinical microbiology 2006;44(10):3600-7.
-
2006: Romero Ana I; Lagging Martin; Westin Johan; Dhillon Amar P; Dustin Lynn B; Pawlotsky Jean-Michel; Neumann Avidan U; Ferrari Carlo; Missale Gabriele; Haagmans Bart L; Schalm Solko W; Zeuzem Stefan; Negro Francesco; Verheij-Hart Elke; Hellstrand Kristoffer;
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
The Journal of infectious diseases 2006;194(7):895-903.
-
2006: Morice Yoann; Cantaloube Jean-François; Beaucourt Stéphanie; Barbotte Laetitia; De Gendt Sija; Goncales Fernando Lopes; Butterworth Lesley; Cooksley Graham; Gish Robert G; Beaugrand Michel; Fay Fabian; Fay Oscar; Gonzalez Jorge E; Martins Regina Maria Bringel; Dhumeaux Daniel; Vanderborght Bart; Stuyver Lieven; Sablon Erwin; de Lamballerie Xavier; Pawlotsky Jean-Michel
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
Journal of medical virology 2006;78(10):1296-303.
-
2006: Challine Dominique; Roudot-Thoraval Françoise; Sabatier Patrick; Dubernet Fabienne; Larderie Patrick; Rigot Pierrette; Pawlotsky Jean-Michel
Serological viral testing of cadaveric cornea donors.
Transplantation 2006;82(6):788-93.
-
2006: Pawlotsky Jean-Michel
Science, medicine and... the markets.
Journal of hepatology 2006;45(3):341-2.
-
2006: Pawlotsky Jean-Michel
[New therapeutic strategies in chronic hepatitis C]
Gastroentérologie clinique et biologique 2006;30(8-9):1009-11.
-
2006: Laperche Syria; Saune Karine; Dény Paul; Duverlie Gilles; Alain Sophie; Chaix Marie-Laure; Gaudy Catherine; Lunel Françoise; Pawlotsky Jean-Michel; Payan Christopher; Pozzetto Bruno; Tamalet Catherine; Thibault Vincent; Vallet Sophie; Bouchardeau Françoise; Izopet Jacques; Lefrère Jean-Jacques
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.
Journal of clinical microbiology 2006;44(2):614-6.
-
2006: Pawlotsky Jean-Michel
Therapy of hepatitis C: from empiricism to eradication.
Hepatology (Baltimore, Md.) 2006;43(2 Suppl 1):S207-20.
-
2006: McHutchison John G; Bartenschlager Ralf; Patel Keyur; Pawlotsky Jean-Michel
The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
Journal of hepatology 2006;44(2):411-21.
-
2006: Pallier Coralie; Castéra Laurent; Soulier Alexandre; Hézode Christophe; Nordmann Patrice; Dhumeaux Daniel; Pawlotsky Jean-Michel
Dynamics of hepatitis B virus resistance to lamivudine.
Journal of virology 2006;80(2):643-53.
-
2006: Pawlotsky Jean-Michel; Gish Robert G
Future therapies for hepatitis C.
Antiviral therapy 2006;11(4):397-408.
-
2006: Chevaliez Stéphane; Pawlotsky Jean-Michel
Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease.
International journal of medical sciences 2006;3(2):35-40.
-
2006: Pawlotsky Jean-Michel
Virology of hepatitis B and C viruses and antiviral targets.
Journal of hepatology 2006;44(1 Suppl):S10-3.
-
2005: Pawlotsky Jean-Michel
The concept of hepatitis B virus mutant escape.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34 Suppl 1():S125-9.
-
2005: Callens Nathalie; Ciczora Yann; Bartosch Birke; Vu-Dac Ngoc; Cosset François-Loïc; Pawlotsky Jean-Michel; Penin François; Dubuisson Jean
Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.
Journal of virology 2005;79(24):15331-41.
-
2005: Simmonds Peter; Bukh Jens; Combet Christophe; Deléage Gilbert; Enomoto Nobuyuki; Feinstone Stephen; Halfon Phillippe; Inchauspé Geneviève; Kuiken Carla; Maertens Geert; Mizokami Masashi; Murphy Donald G; Okamoto Hiroaki; Pawlotsky Jean-Michel; Penin François; Sablon Erwin; Shin-I Tadasu; Stuyver Lieven J; Thiel Heinz-Jürgen; Viazov Sergei; Weiner Amy J; Widell Anders
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.
Hepatology (Baltimore, Md.) 2005;42(4):962-73.
-
2005: Zeuzem Stefan; Pawlotsky Jean-Michel; Lukasiewicz Esther; von Wagner Michael; Goulis Ioannis; Lurie Yoav; Gianfranco Elia; Vrolijk Jan-Maarten; Esteban Juan I; Hezode Christophe; Lagging Martin; Negro Francesco; Soulier Alexandre; Verheij-Hart Elke; Hansen Bettina; Tal Ronen; Ferrari Carlo; Schalm Solko W; Neumann Avidan U;
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.
Journal of hepatology 2005;43(2):250-7.
-
2005: Chevaliez Stéphane; Pawlotsky Jean-Michel
Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
Clinics in liver disease 2005;9(3):371-82, v.
-
2005: Bartosch Birke; Verney Géraldine; Dreux Marlène; Donot Peggy; Morice Yoann; Penin François; Pawlotsky Jean-Michel; Lavillette Dimitri; Cosset Francois-Loïc
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.
Journal of virology 2005;79(13):8217-29.
-
2005: Hézode Christophe; Roudot-Thoraval Françoise; Nguyen Son; Grenard Pascale; Julien Boris; Zafrani Elie-Serge; Pawlotsky Jean-Michel; Dhumeaux Daniel; Lotersztajn Sophie; Mallat Ariane
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2005;42(1):63-71.
-
2005: Lavillette Dimitri; Morice Yoann; Germanidis Georgios; Donot Peggy; Soulier Alexandre; Pagkalos Emanuil; Sakellariou Georgios; Intrator Liliane; Bartosch Birke; Pawlotsky Jean-Michel; Cosset François-Loïc
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
Journal of virology 2005;79(10):6023-34.
-
2005: Gourlain Karine; Soulier Alexandre; Pellegrin Bertrand; Bouvier-Alias Magali; Hézode Christophe; Darthuy Françoise; Rémiré Jocelyne; Pawlotsky Jean-Michel;
Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.
Journal of clinical microbiology 2005;43(4):1669-73.
-
2005: Chevaliez Stéphane; Pawlotsky Jean-Michel
[Screening and diagnosis of hepatitis B and C]
La Revue du praticien 2005;55(6):615-23.
-
2005: Castera Laurent; Chouteau Philippe; Hezode Christophe; Zafrani Elie-Serge; Dhumeaux Daniel; Pawlotsky Jean-Michel
Hepatitis C virus-induced hepatocellular steatosis.
The American journal of gastroenterology 2005;100(3):711-5.
-
2005: Pawlotsky Jean-Michel
Current and future concepts in hepatitis C therapy.
Seminars in liver disease 2005;25(1):72-83.
-
2005: Laperche Syria; Lunel Françoise; Izopet Jacques; Alain Sophie; Dény Paul; Duverlie Gilles; Gaudy Catherine; Pawlotsky Jean-Michel; Plantier Jean-Christophe; Pozzetto Bruno; Thibault Vincent; Tosetti François; Lefrère Jean-Jacques
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.
Journal of clinical microbiology 2005;43(2):733-9.
-
2005: Castera Laurent; Pawlotsky Jean-Michel
Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C.
MedGenMed : Medscape general medicine 2005;7(4):39.
-
2004: Soler Muriel; McHutchison John G; Kwoh T Jesse; Dorr F Andrew; Pawlotsky Jean-Michel
Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Antiviral therapy 2004;9(6):953-68.
-
2004: Patel Keyur; Gordon Stuart C; Jacobson Ira; Hézode Christophe; Oh Esther; Smith Katie M; Pawlotsky Jean-Michel; McHutchison John G
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Journal of hepatology 2004;41(6):935-42.
-
2004: Pawlotsky Jean-Michel
Hepatitis C: it's a long way to new therapy, it's a long way to go...
Gastroenterology 2004;127(5):1629-32.
-
2004: Locarnini Stephen; Hatzakis Angelos; Heathcote Jenny; Keeffe Emmet B; Liang T Jake; Mutimer David; Pawlotsky Jean-Michel; Zoulim Fabien
Management of antiviral resistance in patients with chronic hepatitis B.
Antiviral therapy 2004;9(5):679-93.
-
2004: Challine Dominique; Pellegrin Bertrand; Bouvier-Alias Magali; Rigot Pierrette; Laperche Liliane; Pawlotsky Jean-Michel
HIV and hepatitis C virus RNA in seronegative organ and tissue donors.
Lancet 2004;364(9445):1611-2.
-
2004: Hézode C; Roudot-Thoraval F; Zafrani E-S; Dhumeaux D; Pawlotsky J-M
Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
Journal of viral hepatitis 2004;11(5):455-8.
-
2004: Pawlotsky Jean-Michel
Treating hepatitis C in "difficult-to-treat" patients.
The New England journal of medicine 2004;351(5):422-3.
-
2004: Lefrère Jean-Jacques; Roudot-Thoraval Françoise; Lunel Françoise; Alain Sophie; Chaix Marie-Laure; Dussaix Elisabeth; Gassin Michèle; Izopet Jacques; Pawlotsky Jean-Michel; Payan Christopher; Stoll-Keller Françoise; Thibault Vincent; Trabaud Mary-Anne; Bettinger Dominique; Bogard Marc; Branger Michel; Buffet-Janvresse Claudine; Charrois Anne; Defer Christine; Laffont Catherine; Lerable Joëlle; Levayer Thierry; Martinot-Peignoux Michèle; Mercier Bernard; Rosenberg Arielle R
Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2004;42(5):2027-30.
-
2004: Pellerin Muriel; Lopez-Aguirre Yolanda; Penin François; Dhumeaux Daniel; Pawlotsky Jean-Michel
Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions.
Journal of virology 2004;78(9):4617-27.
-
2004: Pawlotsky Jean-Michel; Dahari Harel; Neumann Avidan U; Hezode Christophe; Germanidis Georgios; Lonjon Isabelle; Castera Laurent; Dhumeaux Daniel
Antiviral action of ribavirin in chronic hepatitis C.
Gastroenterology 2004;126(3):703-14.
-
2004: Castéra L; Hézode C; Roudot-Thoraval F; Lonjon I; Zafrani E-S; Pawlotsky J-M; Dhumeaux D
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
Gut 2004;53(3):420-4.
-
2004: Pawlotsky Jean-Michel
Pathophysiology of hepatitis C virus infection and related liver disease.
Trends in microbiology 2004;12(2):96-102.
-
2004: Pawlotsky Jean-Michel; McHutchison John G
Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003.
Hepatology (Baltimore, Md.) 2004;39(2):554-67.
-
2004: Penin François; Dubuisson Jean; Rey Felix A; Moradpour Darius; Pawlotsky Jean-Michel
Structural biology of hepatitis C virus.
Hepatology (Baltimore, Md.) 2004;39(1):5-19.
-
2004: Oniankitan Owonayo; Duvoux Christophe; Challine Dominique; Mallat Arianne; Chevalier Xavier; Pawlotsky Jean-Michel; Claudepierre Pascal
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.
The Journal of rheumatology 2004;31(1):107-9.
-
2003: Hezode Christophe; Castera Laurent; Chouteau Philippe; Dhumeaux Daniel; Pawlotsky Jean-Michel
[Steasis and hepatitis C]
Gastroentérologie clinique et biologique 2003;27(12):1091-5.
-
2003: Pawlotsky Jean-Michel
The nature of interferon-alpha resistance in hepatitis C virus infection.
Current opinion in infectious diseases 2003;16(6):587-92.
-
2003: Pawlotsky Jean Michel
Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.
Antiviral research 2003;59(1):1-11.
-
2003: Hézode C; Lonjon I; Roudot-Thoraval F; Pawlotsky J-M; Zafrani E-S; Dhumeaux D
Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study.
Alimentary pharmacology & therapeutics 2003;17(8):1031-7.
-
2003: Authier F-J; Bassez G; Payan C; Guillevin L; Pawlotsky J-M; Degos J-D; Gherardi R K; Belec L
Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy.
Neurology 2003;60(5):808-12.
-
2003: Pawlotsky Jean-Michel
Use and interpretation of hepatitis C virus diagnostic assays.
Clinics in liver disease 2003;7(1):127-37.
-
2003: Pawlotsky Jean-Michel
Hepatitis C virus genetic variability: pathogenic and clinical implications.
Clinics in liver disease 2003;7(1):45-66.
-
2003: Bourlet Thomas; Levy Rachel; Laporte Silvy; Blachier Stéphane; Bocket Laurence; Cassuto Guy; Chollet Lionel; Leruez-Ville Marianne; Maertens Anne; Mousnier Fabienne; Pasquier Christophe; Payan Christopher; Pellegrin Bertrand; Schvoerer Evelyne; Zavadzki Patricia; Chouteau Jacques; Duverlie Gilles; Izopet Jacques; Lunel-Fabiani Françoise; Pawlotsky Jean-Michel; Profizi Nerina; Rouzioux Christine; Stoll-Keller Françoise; Thibault Vincent; Wattré Pierre; Pozzetto Bruno
Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.
Journal of clinical microbiology 2003;41(2):789-93.
-
2003: Castéra L; Hézode C; Roudot-Thoraval F; Bastie A; Zafrani E-S; Pawlotsky J-M; Dhumeaux D
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
Gut 2003;52(2):288-92.
-
2003: Hézode C; Lonjon I; Roudot-Thoraval F; Mavier J-P; Pawlotsky J-M; Zafrani E S; Dhumeaux D
Impact of smoking on histological liver lesions in chronic hepatitis C.
Gut 2003;52(1):126-9.
-
2003: Pawlotsky Jean-Michel
Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics.
Journal of hepatology 2003;39 Suppl 1():S31-5.
-
2003: Pawlotsky Jean-Michel
Diagnostic testing in hepatitis C virus infection: viral kinetics and genomics.
Seminars in liver disease 2003;23 Suppl 1():3-11.
-
2002: Pawlotsky Jean-Michel
Use and interpretation of virological tests for hepatitis C.
Hepatology (Baltimore, Md.) 2002;36(5 Suppl 1):S65-73.
-
2002: Castet Valérie; Fournier Chantal; Soulier Alexandre; Brillet Rozenn; Coste Joliette; Larrey Dominique; Dhumeaux Daniel; Maurel Patrick; Pawlotsky Jean-Michel
Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro.
Journal of virology 2002;76(16):8189-99.
-
2002: Challine Dominique; Buisson Marlyse; Cadilhac Michel; Germanidis Georgios; Joab Irene; Eliaszewicz Muriel; Caumes Eric; Flahault Antoine; Fillet Anne-Marie; Pawlotsky Jean-Michel; Seigneurin Jean-Marie
Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Journal of medical virology 2002;67(4):510-5.
-
2002: Bouvier-Alias Magali; Patel Keyur; Dahari Harel; Beaucourt Stéphanie; Larderie Patrick; Blatt Lawrence; Hezode Christophe; Picchio Gaston; Dhumeaux Daniel; Neumann Avidan U; McHutchison John G; Pawlotsky Jean-Michel
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
Hepatology (Baltimore, Md.) 2002;36(1):211-8.
-
2002: Soler Muriel; Pellerin Muriel; Malnou Cécile E; Dhumeaux Daniel; Kean Katherine M; Pawlotsky Jean-Michel
Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.
Virology 2002;298(1):160-73.
-
2002: Pawlotsky Jean-Michel
Molecular diagnosis of viral hepatitis.
Gastroenterology 2002;122(6):1554-68.
-
2002: Pawlotsky Jean-Michel
[Management of patients with hepatitis C virus infection. Virological tests]
Gastroentérologie clinique et biologique 2002;26 Spec No 2():B180-7.
-
2002: Quadri Rafael; Giostra Emiliano; Roskams Tania; Pawlotsky Jean-Michel; Mentha Gilles; Rubbia-Brandt Laura; Perrin Luc; Hadengue Antoine; Negro Francesco
Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.
Transplantation 2002;73(3):373-8.
-
2002: Duvoux Christophe; Tran Ngoc Anh; Intrator Liliane; Hézode Christophe; Germanidis Georgios; Pawlotsky Jean-Michel; Cherqui Daniel; Dhumeaux Daniel
Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
Transplant international : official journal of the European Society for Organ Transplantation 2002;15(1):3-9.
-
2001: Challine D; Roudot-Thoraval F; Sarah T; Laperche L; Boisson B; Mauberquez S; Dubernet F; Rigot P; Lefrère F; Mercier B; Brossard Y; Rouet F; Girot R; Loiseau P; Girard D; Claquin J; Loty B; Lerable J; Mariotti M; Pawlotsky J M; Lefrère J J
Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses.
Transfusion 2001;41(9):1120-5.
-
2001: Penin F; Combet C; Germanidis G; Frainais P O; Deléage G; Pawlotsky J M
Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
Journal of virology 2001;75(12):5703-10.
-
2001: Pawlotsky J M
[Hepatitis C virus and immune response]
Gastroentérologie clinique et biologique 2001;25(4 Suppl):B123-33.
-
2000: Pawlotsky J M
Hepatitis C virus resistance to antiviral therapy.
Hepatology (Baltimore, Md.) 2000;32(5):889-96.
-
2000: Pawlotsky J M; Bouvier-Alias M; Hezode C; Darthuy F; Remire J; Dhumeaux D
Standardization of hepatitis C virus RNA quantification.
Hepatology (Baltimore, Md.) 2000;32(3):654-9.
-
2000: Lefrère J J; Lerable J; Mariotti M; Bogard M; Thibault V; Frangeul L; Loiseau P; Bouchardeau F; Laperche S; Pawlotsky J M; Cantaloube J F; Biagini P; de Lamballerie X; Izopet J; Defer C; Lepot I; Poveda J D; Dussaix E; Gerolami V; Halfon P; Buffet-Janvresse C; Férec C; Mercier B; Marcellin P; Martinot-Peignoux M; Gassain M
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.
Journal of virological methods 2000;85(1-2):117-24.
-
2000: Pawlotsky J M; Bastie A; Hézode C; Lonjon I; Darthuy F; Rémiré J; Dhumeaux D
Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays.
Journal of virological methods 2000;85(1-2):11-21.
-
2000: Bastie A; Castera L; Roudot-Thoraval F; Dhumeaux D; Pawlotsky J M
Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: a wrong track.
Hepatology (Baltimore, Md.) 2000;31(2):547-8.
-
1999: Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Lonjon I; Bastie A; Duvoux C; Pawlotsky J M; Zafrani E S; Amselem S; Dhumeaux D
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
Journal of hepatology 1999;31(6):979-84.
-
1999: Martinot-Peignoux M; Roudot-Thoraval F; Mendel I; Coste J; Izopet J; Duverlie G; Payan C; Pawlotsky J M; Defer C; Bogard M; Gerolami V; Halfon P; Buisson Y; Fouqueray B; Loiseau P; Lamoril J; Lefrere J J; Marcellin P
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.
Journal of viral hepatitis 1999;6(6):435-43.
-
1999: Pawlotsky J M; Dhumeaux D
[The G virus: the orphan virus]
Presse médicale (Paris, France : 1983) 1999;28(34):1882-3.
-
1999: Duvoux C; Pawlotsky J M; Bastie A; Cherqui D; Soussy C J; Dhumeaux D
Low HCV replication levels in end-stage hepatitis C virus-related liver disease.
Journal of hepatology 1999;31(4):593-7.
-
1999: Pawlotsky J M; Germanidis G
The non-structural 5A protein of hepatitis C virus.
Journal of viral hepatitis 1999;6(5):343-56.
-
1999: Germanidis G; haioun C; Dhumeaux D; Reyes F; Pawlotsky J M
Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma.
Hepatology (Baltimore, Md.) 1999;30(3):822-3.
-
1999: Hézode C; Duvoux C; Germanidis G; Roudot-Thoraval F; Vincens A L; Gaulard P; Cherqui D; Pawlotsky J M; Dhumeaux D
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
Hepatology (Baltimore, Md.) 1999;30(3):775-8.
-
1999: Pawlotsky J M; Germanidis G; Frainais P O; Bouvier M; Soulier A; Pellerin M; Dhumeaux D
Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.
Journal of virology 1999;73(8):6490-9.
-
1999: Pawlotsky J M
Hepatitis C virus (HCV) NS5A protein: role in HCV replication and resistance to interferon-alpha.
Journal of viral hepatitis 1999;6 Suppl 1():47-8.
-
1999: Castera L; Dhumeaux D; Pawlotsky J M
[The role of virologic tests in the treatment of chronic hepatitis C]
Gastroentérologie clinique et biologique 1999;23(6-7):707-9.
-
1999: Lefrère J J; Cantaloube J F; Defer C; Mercier B; Loiseau P; Vignon D; Pawlotsky J M; Biagini P; Lerable J; Rouger P; Roudot-Thoraval F; Férec C
Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing.
Journal of virological methods 1999;80(1):33-44.
-
1999: Pawlotsky J M; Martinot-Peignoux M; Poveda J D; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P
Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
Journal of virological methods 1999;79(2):227-35.
-
1999: Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Pawlotsky J M; Zafrani E S; Amslem S; Dhumeaux D
Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis.
Hepatology (Baltimore, Md.) 1999;29(4):1338.
-
1999: Pawlotsky J M
Diagnostic tests for hepatitis C.
Journal of hepatology 1999;31 Suppl 1():71-9.
-
1998: Lefrère J J; Coste J; Defer C; Mercier B; Férec C; Loiseau P; Portelette E; Mariotti M; Lerable J; Rouger P; Pawlotsky J M
Screening blood donations for viral genomes: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection.
Transfusion 1998;38(10):915-23.
-
1998: Pawlotsky J M; Lonjon I; Hezode C; Raynard B; Darthuy F; Remire J; Soussy C J; Dhumeaux D
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?
Hepatology (Baltimore, Md.) 1998;27(6):1700-2.
-
1998: Pawlotsky J M
Genetic heterogeneity and properties of hepatitis C virus.
Acta gastro-enterologica Belgica 1998;61(2):189-91.
-
1998: Pawlotsky J M; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy C J; Dhumeaux D
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Journal of medical virology 1998;54(4):256-64.
-
1998: Pawlotsky J M; Germanidis G; Neumann A U; Pellerin M; Frainais P O; Dhumeaux D
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
Journal of virology 1998;72(4):2795-805.
-
1998: Zarski J P; Bohn B; Bastie A; Pawlotsky J M; Baud M; Bost-Bezeaux F; Tran van Nhieu J; Seigneurin J M; Buffet C; Dhumeaux D
Characteristics of patients with dual infection by hepatitis B and C viruses.
Journal of hepatology 1998;28(1):27-33.
-
1998: Pawlotsky J M; Roudot-Thoraval F; Muerhoff A S; Pellerin M; Germanidis G; Desai S M; Bastie A; Darthuy F; Rémiré J; Zafrani E S; Soussy C J; Mushahwar I K; Dhumeaux D
GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
Journal of medical virology 1998;54(1):26-37.
-
1998: Hezode C; Cazeneuve C; Coué O; Pawlotsky J M; Zafrani E S; Amselem S; Dhumeaux D
Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C.
Hepatology (Baltimore, Md.) 1998;27(1):306.
-
1998: Pawlotsky J M; Gretch D R
Molecular tools for the treatment of hepatitis C.
Antiviral therapy 1998;3(Suppl 3):45-55.
-
1997: Bogard M; Buffet-Janvresse C; Cantaloube J F; Biagini P; Duverlie G; Castelain S; Izopet J; Dubois M; Defer C; Lepot I; Coste J; Marcellin P; Martinot-Peignoux M; Halfon P; Gerolami V; Frangeul L; Pawlotsky J M; Roudot-Thoraval F; Dussaix E; Loiseau P; Ravera N; Lewin P; Lamoril J; Lerable J; Lebon P
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum.
Journal of clinical microbiology 1997;35(12):3298-300.
-
1997: Prescott L E; Berger A; Pawlotsky J M; Conjeevaram P; Pike I; Simmonds P
Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Journal of medical virology 1997;53(3):237-44.
-
1997: Roudot-Thoraval F; Bastie A; Pawlotsky J M; Dhumeaux D
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
Hepatology (Baltimore, Md.) 1997;26(2):485-90.
-
1997: Pawlotsky J M
Measuring hepatitis C viremia in clinical samples: can we trust the assays?
Hepatology (Baltimore, Md.) 1997;26(1):1-4.
-
1997: Pawlotsky J M; Prescott L; Simmonds P; Pellet C; Laurent-Puig P; Labonne C; Darthuy F; Remire J; Duval J; Buffet C; Etienne J P; Dhumeaux D; Dussaix E
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay.
Journal of clinical microbiology 1997;35(7):1734-9.
-
1997: Pawlotsky J M; Bastie A; Lonjon I; Rémiré J; Darthuy F; Soussy C J; Dhumeaux D
What technique should be used for routine detection and quantification of HBV DNA in clinical samples?
Journal of virological methods 1997;65(2):245-53.
-
1997: Bralet M P; Roudot-Thoraval F; Pawlotsky J M; Bastie A; Tran Van Nhieu J; Duval J; Dhumeaux D; Zafrani E S
Histopathologic impact of GB virus C infection on chronic hepatitis C.
Gastroenterology 1997;112(1):188-92.
-
1997: Pawlotsky J M
[Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?]
Gastroentérologie clinique et biologique 1997;21(1 Pt 2):S41-50.
-
1996: Duvoux C; Pawlotsky J M; Cherqui D; Métreau J M; Fagniez P L; Duval J; Dhumeaux D
Initial clinical patterns of hepatitis C virus reinfection after liver transplantation for hepatitis C virus-related cirrhosis.
Transplantation proceedings 1996;28(5):2844-5.
-
1996: Pawlotsky J M; Roudot-Thoraval F; Bastie A; Darthuy F; Rémiré J; Métreau J M; Zafrani E S; Duval J; Dhumeaux D
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
The Journal of infectious diseases 1996;174(1):1-7.
-
1996: Pawlotsky J M; Roudot-Thoraval F; Bastie A; Pellet C; Duval J; Dhumeaux D
Are hepatitis C virus genotypes 1a and 1b so different?
Hepatology (Baltimore, Md.) 1996;23(5):1289-91.
-
1996: Pawlotsky J M; Lunel F; Zarski J P; Laurent-Puig P; Bréchot C
[Biological diagnosis of hepatitis C virus infection. Role of serological and molecular tests]
Gastroentérologie clinique et biologique 1996;20(2):146-61.
-
1996: Pawlotsky J M; Hovanessian A G; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Antimicrobial agents and chemotherapy 1996;40(2):320-4.
-
1996: Pawlotsky J M; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
Journal of clinical microbiology 1996;34(1):80-3.
-
1996: Serfaty L; Chazouillères O; Pawlotsky J M; Andreani T; Pellet C; Poupon R
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
Gastroenterology 1996;110(1):291-5.
-
1996: Rostoker G; Pawlotsky J M; Bastie A; Weil B; Dhumeaux D
Type I membranoproliferative glomerulonephritis and HCV infection.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 4():22-4.
-
1995: Pawlotsky J M; Roudot-Thoraval F; Bastie A; Duval J; Dhumeaux D
Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy?
Journal of hepatology 1995;23(6):760-1.
-
1995: Pawlotsky J M; Bouvier M; Fromont P; Deforges L; Duval J; Dhumeaux D; Bierling P
Hepatitis C virus infection and autoimmune thrombocytopenic purpura.
Journal of hepatology 1995;23(6):635-9.
-
1995: Pawlotsky J M; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Journal of medical virology 1995;47(3):285-91.
-
1995: Stuyver L; Wyseur A; van Arnhem W; Lunel F; Laurent-Puig P; Pawlotsky J M; Kleter B; Bassit L; Nkengasong J; van Doorn L J
Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.
Virus research 1995;38(2-3):137-57.
-
1995: Pawlotsky J M; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(10):857-62.
-
1995: Pawlotsky J M; Benchiki H; Pellet C; Duval J; Dhumeaux D; Revuz J; Bagot M
Lichen planus and hepatitis C virus (HCV)-related chronic hepatitis: evaluation of HCV genotypes.
The British journal of dermatology 1995;133(4):666-7.
-
1995: Pawlotsky J M; Dhumeaux D; Bagot M
Hepatitis C virus in dermatology. A review.
Archives of dermatology 1995;131(10):1185-93.
-
1995: Duvoux C; Pawlotsky J M; Cherqui D; Tran van Nhieu J; Metreau J M; Fagniez P L; Duval J; Zafrani E S; Dhumeaux D
Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection.
Transplantation 1995;60(5):457-61.
-
1995: Pawlotsky J M; Bélec L; Grésenguet G; Deforges L; Bouvier M; Duval J; Dhumeaux D
High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic.
Journal of medical virology 1995;46(3):269-72.
-
1995: Pawlotsky J M; Tsakiris L; Roudot-Thoraval F; Pellet C; Stuyver L; Duval J; Dhumeaux D
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.
The Journal of infectious diseases 1995;171(6):1607-10.
-
1995: Pawlotsky J M; Roudot-Thoraval F; Pellet C; Aumont P; Darthuy F; Remire J; Duval J; Dhumeaux D
Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
Journal of clinical microbiology 1995;33(5):1357-9.
-
1995: Pawlotsky J M; Roudot-Thoraval F; Simmonds P; Mellor J; Ben Yahia M B; André C; Voisin M C; Intrator L; Zafrani E S; Duval J; Dhumeaux D
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes.
Annals of internal medicine 1995;122(3):169-73.
-
1995: Pawlotsky J M; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J
Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
Journal of medical virology 1995;45(1):68-70.
-
1994: Lamoril J; Lunel F; Laurent-Puig P; Defer C; Loiseau P; Lefrère J J; Pawlotsky J M; Marcellin P; Bouchardeau F; Bogard M
Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Group d'Etudes Moléculaires des Hépatites (GEMHEP).
Journal of hepatology 1994;21(1):133-4.
-
1994: Pawlotsky J M; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
Journal of clinical microbiology 1994;32(5):1357-9.
-
1994: Pawlotsky J M; Ben Yahia M; Andre C; Voisin M C; Intrator L; Roudot-Thoraval F; Deforges L; Duvoux C; Zafrani E S; Duval J
Immunological disorders in C virus chronic active hepatitis: a prospective case-control study.
Hepatology (Baltimore, Md.) 1994;19(4):841-8.
-
1994: Jubert C; Pawlotsky J M; Pouget F; Andre C; DeForges L; Bretagne S; Mavier J P; Duval J; Revuz J; Dhumeaux D
Lichen planus and hepatitis C virus--related chronic active hepatitis.
Archives of dermatology 1994;130(1):73-6.
-
1994: Pawlotsky J M; Marcellin P; Trépo C; Dhumeaux D
[Treatment of viral hepatitis C]
Gastroentérologie clinique et biologique 1994;18(4):362-73.
-
1993: Roudot-Thoraval F; Pawlotsky J M; Thiers V; Deforges L; Girollet P P; Guillot F; Huraux C; Aumont P; Brechot C; Dhumeaux D
Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.
Hepatology (Baltimore, Md.) 1993;17(5):772-7.
-
1993: Pawlotsky J M; Deforges L; Bretagne S; André C; Métreau J M; Thiers V; Zafrani E S; Goossens M; Duval J; Mavier J P
Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis.
Gut 1993;34(2 Suppl):S66-8.
-
1993: Roudot-Thoraval F; Pawlotsky J M; Deforges L; Girollet P P; Dhumeaux D
Anti-HCV seroprevalence in pregnant women in France.
Gut 1993;34(2 Suppl):S55-6.
-
1992: Pawlotsky J M; Andre C; Metreau J M; Beaugrand M; Zafrani E S; Dhumeaux D
Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1992;16(1):127-31.
Sign-in to see more
